Hydroxychloroquine
Plaquenil, SOVUNA
DMARD (Antimalarial)
NADAC/unit
$0.1636
No Shortage
Tier 1: 57.8%
13 Manufacturers
19 ANDAs
Hydroxychloroquine sulfate tablets are an antimalarial and antirheumatic indicated for the: Treatment of uncomplicated malaria due to Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, a....
vs. brand Plaquenil: Generic saves up to 98% per unit
Active Shortages
2026-01-05 Discontinuation of the manufacture of the drug, Teva Pharmaceuticals USA, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCADVANZ PHARMA (US) CORPALKALOIDA CHEMICAL CO ZRTAMNEAL PHARMACEUTICALS CO GMBHAPPCO PHARMA LLCAUROBINDO PHARMA USA INCCHARTWELL RX SCIENCES LLCCREEKWOOD PHARMACEUTICALS LLCIPCA LABORATORIES LTDLAURUS LABS LTDNOVITIUM PHARMA LLCSANDOZ INCSENORES PHARMACEUTICALS INCTEVA PHARMACEUTICALS USAZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.